Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • RSS feeds
Research

Characteristics of high–drug-cost beneficiaries of public drug plans in 9 Canadian provinces: a cross-sectional analysis

Mina Tadrous, Diana Martins, Muhammad M. Mamdani and Tara Gomes
April 28, 2020 8 (2) E297-E303; DOI: https://doi.org/10.9778/cmajo.20190231
Mina Tadrous
Women’s College Hospital Research Institute (Tadrous); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Li Ka Shing Knowledge Institute (Martins, Gomes) and Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael’s Hospital; Institute of Health Policy, Management and Evaluation (Mamdani, Gomes), University of Toronto; Department of Medicine (Mamdani), Faculty of Medicine, University of Toronto, Toronto, Ont.
PharmD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diana Martins
Women’s College Hospital Research Institute (Tadrous); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Li Ka Shing Knowledge Institute (Martins, Gomes) and Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael’s Hospital; Institute of Health Policy, Management and Evaluation (Mamdani, Gomes), University of Toronto; Department of Medicine (Mamdani), Faculty of Medicine, University of Toronto, Toronto, Ont.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad M. Mamdani
Women’s College Hospital Research Institute (Tadrous); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Li Ka Shing Knowledge Institute (Martins, Gomes) and Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael’s Hospital; Institute of Health Policy, Management and Evaluation (Mamdani, Gomes), University of Toronto; Department of Medicine (Mamdani), Faculty of Medicine, University of Toronto, Toronto, Ont.
PharmD MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tara Gomes
Women’s College Hospital Research Institute (Tadrous); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Li Ka Shing Knowledge Institute (Martins, Gomes) and Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael’s Hospital; Institute of Health Policy, Management and Evaluation (Mamdani, Gomes), University of Toronto; Department of Medicine (Mamdani), Faculty of Medicine, University of Toronto, Toronto, Ont.
MHSc PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 8 no. 2 E297-E303
DOI 
https://doi.org/10.9778/cmajo.20190231
PubMed 
32345708
History 
  • Published online April 28, 2020.
Copyright & Usage 
Copyright 2020, Joule Inc. or its licensors

Author Information

  1. Mina Tadrous, PharmD PhD,
  2. Diana Martins, MSc,
  3. Muhammad M. Mamdani, PharmD MPH,
  4. Tara Gomes, MHSc PhD
  1. Women’s College Hospital Research Institute (Tadrous); Leslie Dan Faculty of Pharmacy (Tadrous, Mamdani, Gomes), University of Toronto; Li Ka Shing Knowledge Institute (Martins, Gomes) and Li Ka Shing Centre for Healthcare Analytics Research and Training (Mamdani), St. Michael’s Hospital; Institute of Health Policy, Management and Evaluation (Mamdani, Gomes), University of Toronto; Department of Medicine (Mamdani), Faculty of Medicine, University of Toronto, Toronto, Ont.
  1. Correspondence to: Mina Tadrous, mina.tadrous{at}wchospital.ca
View Full Text

Usage statistics: April 2020 to August 2025

AbstractFullPdf
Apr 20205941526
May 202014636256
Jun 202015216315
Jul 202077204
Aug 202021247
Sep 2020291713
Oct 202034316
Nov 202024509
Dec 2020232513
Jan 202133277
Feb 2021181912
Mar 202127327
Apr 202112165
May 20211285
Jun 2021211613
Jul 202165015
Aug 202151812
Sep 202113110
Oct 202152829
Nov 202163721
Dec 20216214
Jan 20224236
Feb 20221204
Mar 20223339
Apr 20228346
May 202241916
Jun 202282821
Jul 20223185
Aug 202262315
Sep 20223468
Oct 20224319
Nov 20228358
Dec 202211193
Jan 20238334
Feb 202333119
Mar 202321529
Apr 20233242
May 20230217
Jun 20233257
Jul 20231365
Aug 20232309
Sep 20236404
Oct 20231418
Nov 202334810
Dec 202323913
Jan 202414265
Feb 20242317
Mar 20246498
Apr 2024712814
May 202412148
Jun 202426414
Jul 202412613
Aug 202443610
Sep 202443417
Oct 202435220
Nov 202435413
Dec 202436222
Jan 202522817
Feb 2025193217
Mar 2025835137
Apr 2025955131
May 20251036041
Jun 2025395827
Jul 2025542439
Aug 202515835
PreviousNext
Back to top

In this issue

CMAJ Open: 8 (2)
Vol. 8, Issue 2
1 Apr 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Characteristics of high–drug-cost beneficiaries of public drug plans in 9 Canadian provinces: a cross-sectional analysis
(Your Name) has sent you a message from CMAJ Open
(Your Name) thought you would like to see the CMAJ Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Characteristics of high–drug-cost beneficiaries of public drug plans in 9 Canadian provinces: a cross-sectional analysis
Mina Tadrous, Diana Martins, Muhammad M. Mamdani, Tara Gomes
Apr 2020, 8 (2) E297-E303; DOI: 10.9778/cmajo.20190231

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Characteristics of high–drug-cost beneficiaries of public drug plans in 9 Canadian provinces: a cross-sectional analysis
Mina Tadrous, Diana Martins, Muhammad M. Mamdani, Tara Gomes
Apr 2020, 8 (2) E297-E303; DOI: 10.9778/cmajo.20190231
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Comparison of claims from high-drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
  • Medication use and its impact on high-cost health care users among older adults: protocol for the population-based matched cohort HiCOSTT study
  • Google Scholar

Similar Articles

Collections

  • Nonclinical
    • Health Economics - see also Medicare
  • Clinical
    • Drugs
      • Other drug use
    • Geriatric Medicine
      • Polypharmacy

Content

  • Current issue
  • Past issues
  • Collections

About

  • General Information
  • Staff
  • Editorial Board
  • Advisory Panel
  • Contact Us
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2025, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

 

Powered by HighWire